Venture Lab Program (International)

Venture Lab Program (International) is sponsored by BioInnovation Institute (BII). The BII International Venture Lab program supports European (non-Danish) early-stage life science startups in transforming cutting-edge ideas into validated concepts.

* [[#IABV2SETTINGS#]](https://bii. dk/programs/venture-lab/#) * Google 1Learn more about this provider Some of the data collected by this provider is for the purposes of personalization and measuring advertising effectiveness. * Google 5Learn more about this provider Some of the data collected by this provider is for the purposes of personalization and measuring advertising effectiveness.

[Cross-domain consent[#BULK_CONSENT_DOMAINS_COUNT#]](https://bii. dk/programs/venture-lab/#) List of domains your consent applies to: [#BULK_CONSENT_DOMAINS#] [#IABV2_BODY_LEGITIMATE_INTEREST_INTRO#] [#IABV2_BODY_PREFERENCE_INTRO#] [#IABV2_BODY_PURPOSES_INTRO#] [#IABV2_BODY_FEATURES_INTRO#] [#IABV2_BODY_PARTNERS_INTRO#] Please state your consent ID and date when you contact us regarding your consent.

**Do not sell or share my personal information** Deny Allow selection Customize Allow all Turning breakthrough science into a company is a journey. In Venture Lab, we provide the funding, knowledge, infrastructure, and network to empower you to to take the first steps - and navigate the critical early stages. We offer founder-friendly terms, giving you the flexibility to grow, while building the skills and resilience to thrive.

As part of Venture Lab you also become part of the vibrant BII community, with peers and experts working alongside you to mature your science, business, and team. We help you get investment-ready, connecting you with the right people and preparing you for the next stage. In short, we support your startup journey from day one - helping you create lasting impact and bring science to life.

**Purpose**Addressing early-stage technical and commercial risks while developing resilient founders with leadership capacity to bring new solutions and products to market **Program support**Scientific maturation, team development and entrepreneurial training through our start-up platform as well as tailored guidance provided by an anchor.

### BII Venture Lab Program Evidence-based idea, established founder team, and clear understanding of unique value proposition and differentiation. BII Venture Lab can only support early-stage companies with no commercial investments/ownership. Human Health (Therapeutics & Health Tech), Planetary Health and Quantum.

DKK 4. 2M convertible loan On acceptance into the Program, your start-up must be incorporated in Denmark (Danish CVR. number) and be headquartered, operating, and led from Denmark*.

12 months, physical touch points in Copenhagen, Denmark. September 10th 2026 - 14:00 CET Apply nowBook a meetingGuidelines ### BII International Venture Lab Program Evidence-based idea, established founder team, and clear understanding of unique value proposition and differentiation. BII International Venture Lab can also support early-stage companies with commercial investments/ownership.

Human Health (Therapeutics only) and Planetary Health Up to EUR 500. 000 convertible loan On acceptance into the Program, your start-up must be incorporated in the European Economic Area (except Denmark), Switzerland, or United Kingdom and be headquartered, operating, and led from such country. Special focus is given to (future) companies from Italy.

12 months, physical touch points in Copenhagen, Denmark. No deadline, to qualify for next evaluation (October 14, 2026) Submit your pre-application by August 18th 2026 Submit your full application by August 25th 2026.

Apply nowBook a meetingGuidelines ### BII Venture Lab Program ### BII International Venture Lab Program Evidence-based idea, established founder team, and clear understanding of unique value proposition and differentiation. BII Venture Lab can only support early-stage companies with no commercial investments/ownership. Evidence-based idea, established founder team, and clear understanding of unique value proposition and differentiation.

BII International Venture Lab can also support early-stage companies with commercial investments/ownership. Human Health (Therapeutics & Health Tech), Planetary Health and Quantum. Human Health (Therapeutics only) and Planetary Health DKK 4.

2M convertible loan Up to EUR 500. 000 convertible loan On acceptance into the Program, your start-up must be incorporated in Denmark (Danish CVR. number) and be headquartered, operating, and led from Denmark*.

On acceptance into the Program, your start-up must be incorporated in the European Economic Area (except Denmark), Switzerland, or United Kingdom and be headquartered, operating, and led from such country. Special focus is given to (future) companies from Italy. 12 months, physical touch points in Copenhagen, Denmark.

12 months, physical touch points in Copenhagen, Denmark. September 10th 2026 - 14:00 CET No deadline, to qualify for next evaluation (October 14, 2026) Submit your pre-application by August 18th 2026 Submit your full application by August 25th 2026.

Apply nowBook a meetingGuidelines Apply nowBook a meetingGuidelines > “The Venture Lab program provides valuable help and many business insights to become more certain about the value proposition of your company. ” Morten Østergaard Andersen CEO, Nordic Microbes ## Latest start-ups and projects Please find an overview of the start-ups that are currently part of our Venture Lab program.

All start-ups and projects Venture Lab Planetary health Étiquette Étiquette redesigned fermentation to create alcohol free wine with full flavour and structure, seamlessly inside existing wineries. Visit site Venture Lab Human health Cerentry Enabling systemic drug delivery to the brain.

Visit site Venture Lab Planetary health 2D Accelerating the green transition through sustainable biotechnologies powered by scalable, affordable graphene. Visit site Venture Lab Human health 1st Biome Developing next-generation probiotics with enhanced health benefits to prevent serious health conditions.

Visit site Venture Lab Planetary health Vasuqi Eliminating the toughest industrial pollutants with light - unlocking true water circularity. Visit site Venture Lab Human health Equilibrium Diagnostics Non-invasive assessment of the kidney's tubular function based on urinary ammonium and pH in chronic kidney disease.

Visit site Venture Lab Human health Anorit Medical On a mission to increase survival from cardiac arrest, with an automatic ventilation device for bystanders. Visit site Venture Lab Human health Ibnova Therapeutics Transforming the treatment of heart disease through tissue engineering. Visit site Venture Lab Societal resilience QFactory Building bespoke quantum systems for next-generation quantum sensing.

Visit site Venture Lab Human health Heureka Therapeutics Heureka wants to treat fatty liver disease with a dual-acting peptide that can safely restore liver metabolism and reverse the disease, which offer... Visit site Venture Lab Human health Combotope Therapeutics Combotope targets sweet tumors and not healthy cells, providing safer antibody therapies.

Visit site Venture Lab Planetary health SAGAVA Providing a carbon-negative process that generates biogenic fuels and sustainable power by repurposing waste. Visit site Venture Lab Planetary health Pura Futura Developing a Plug&Play PtX that unlocks the sector coupling between renewable power and green natural gas.

Visit site Venture Lab Societal resilience Celare Quantum Communications Using quantum technology to secure the most sensitive data - today and in the quantum future. Visit site Venture Lab Human health 3Sonic Improves patient care by 3D ultrasound technology leading to precise surgical cancer treatment.

Visit site Venture Lab Human health Proxi Biotech Proxi Biotech disrupts the vicious cycle of recurrent bacterial infections with a novel vaccine platform. Visit site Venture Lab Human health Beech Biotech Making mother-only antibodies treating preeclampsia in the mother without affecting her baby.

Visit site Venture Lab Human health Incipiam Pharma Developing small molecule weight loss drugs that increase fat burning directly in the fat cells. Visit site Venture Lab Human health Synuca Therapeutics Develops first-in-class innovative small molecule calcium modulators to slow progression of Parkinson's.

Visit site Venture Lab Human health Gefjon Pharma Combats the challenges of antimicrobial resistance by providing a cost-effective platform technology. Visit site Venture Lab Planetary health Yngvi Bio Helping farmers globally by safeguarding their crops with targeted insect pest control. Visit site Venture Lab Planetary health Cerelixis Working to provide innovative solutions improving crop productivity for sustainable agriculture.

Visit site Venture Lab Planetary health microMiner Working to make the recycling process for EV-batteries sustainable by replacing polluting chemicals. Visit site Venture Lab Human health Akasi Pharma Akasi Pharma is inspired by nature to develop the next generation of non-opioid therapeutics to treat pain. Visit site All start-ups and projects ## Frequently asked questions What if my company fails?

The loan includes no personal guarantees of repayment from the founders. In case of liquidation (company closure), the unrepaid balance of the loan will be converted into a grant from BII (Note: this does not apply to the International Venture Lab). Can I apply to Venture Lab if I have received funding from elsewhere?

Yes, but as a rule of thumb, only non-dilutive funding is accepted unless you applied to the International Venture Lab. If you apply to the Venture Lab a small investment from friends and family is fine, but professional investments and certain types of loans may exclude your company from applying. Please be aware of the BII eligibility criteria for company ownership, which can be found in the Application Guidelines.

Can I receive funding from elsewhere while my project is a part of Venture Lab? Yes, but professional investments and certain types of loans may exclude your company from applying for the Venture House program if you wish to do so after Venture Lab (Note: this exclusion does not apply to the International Venture Lab). We encourage companies to seek non-dilutive funding from, e.g., Danish governmental programs or EU programs.

I don't have a company yet - is that a problem? Not at all. You can apply without a company but you need to establish a Danish company if you are accepted into to program.

### BioInnovation Institute Foundation Visit our some-linkedin page